MiRXES Overview
- Founded
-
2014

- Status
-
Private
- Employees
-
182

- Latest Deal Type
-
2ndary - Private
- Investors
-
8
MiRXES General Information
Description
Developer of a diagnostic test platform designed to detect cancer at an asymptomatic stage. The company specializes in providing clinical diagnostic tools that seek to recognize early cancer detection in clinical examinations with its microRNA quantification test, enabling healthcare professionals to identify cancer at early stages.
Contact Information
Website
www.mirxes.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Primary Office
- 2 Tukang Innovation Grove
- Number 09-02 JTC MedTech Hub
- Singapore, 618305
- Singapore
+65 6816 0000
MiRXES Timeline
MiRXES Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Secondary Transaction - Private | 03-Oct-2022 | 00000 | Completed | Generating Revenue | ||
4. Later Stage VC (Series C) | 08-Jul-2021 | 0000 | 00000 | Completed | Generating Revenue | |
3. Early Stage VC (Series A) | 11-Jul-2018 | 0000 | 000.00 | 00000 | Completed | Generating Revenue |
2. Grant | 09-Mar-2016 | $250.00 | $2.84M | Completed | Generating Revenue | |
1. Early Stage VC | 01-Jan-2016 | $2.84M | $2.84M | Completed | Generating Revenue |
MiRXES Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of a diagnostic test platform designed to detect cancer at an asymptomatic stage. The company specializes in p
Diagnostic Equipment
Singapore, Singapore
182
As of 2022
00000
00000000000
00000
MiRXES Competitors (11)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Genomic Expression | Venture Capital-Backed | Beverly, MA | 00 | 00.00 | 0000000000 0 | 00.00 |
00000000 | Formerly VC-backed | South San Francisco, CA | 000 | 00000 | 000000 - 000 | 00000 |
000000000 | Formerly VC-backed | Paris, France | 000 | 00000 | 00000000 | 00000 |
0000000 0000000000 | Formerly VC-backed | Berkeley, CA | 000 | 00000 | 00000000 | 00000 |
0000000 0000000000 | Formerly VC-backed | Cambridge, MA | 0000 | 00000 | 00000000 | 00000 |
MiRXES Executive Team (9)
MiRXES Board Members (3)
Name | Representing | Role | Since |
---|---|---|---|
Da Liu | China Resources Capital Management | Board Member | 000 0000 |
Isaac Ho | MiRXES | Chief Investment Officer & Board Member | 000 0000 |
Lihan Zhou Ph.D | MiRXES | Co-Founder, Chief Executive Officer & Board Member | 000 0000 |
MiRXES Signals
MiRXES Investors (8)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
CCB International | PE/Buyout | Minority | 000 0000 | 000000 0 | |
CDG Capital | Growth/Expansion | Minority | 000 0000 | 000000 0 | |
China Resources Capital Management | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
EDBI | Venture Capital | Minority | 000 0000 | 000000 0 | |
Keytone Ventures | Venture Capital | Minority | 000 0000 | 000000 0 |
MiRXES Investments (2)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
000000 | 31-Mar-2022 | 00000 0000 | 00.00 | Clinics/Outpatient Services | |
Ark (Diagnostic Equipment) | 01-Jan-2018 | Joint Venture | Diagnostic Equipment | 0000000 0 |
MiRXES Exits (1)
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
000 (0000000000 00 | 01-Jan-2018 | 00000 0000000 | Completed |
|